Robertson Stephen P.'s Form 4/A amendment
AmendedAurinia Pharmaceuticals Inc. (AUPH) · filed Feb 22, 2024
- Accession no.
- 0001600620-24-000015
- Filed
- Feb 22, 2024
- Trade date
- Mar 2, 2023
- Filing delay
- 357 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 6, 2023
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $172.5K. It was filed 357 days after the trade.
This amendment replaces 0001628280-23-006530 (filed Mar 6, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robertson Stephen P.CIK 0001837798 | Officer (EVP, General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Common Stock | AGrant or awardAcquired | +204,810 | – | – | 322,766 | Direct | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −19,644 | $8.78 | −$172,474.32 | 303,122 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.